Stig Løkke Pedersen

Biography

 Board member of InDex Pharmaceuticals Holding AB since 2016 and board member of InDex Pharmaceuticals AB since 2012, Pedersen is chairman of the board of Nuevolution AB, moksha8 Ltd, Transmedica A/S and SSI-Diagnostics A/S as well as board member of MSI Ltd, SkyBrands A/S, BroenLab A/S and Catacap A/S.  Pedersen has been chairman of the board of x3 Capital, Microlytic ApS and Ergolet A/S until 2015 and of Chemometec A/S until 2014 as well as board member of Executive Capital A/S until 2014.   Pedersen was during a period of nearly 20 years part of the management team of the Danish pharmaceutical group H. Lundbeck A /S, including 10 years as executive VP and member of Lundbeck’s group management. From 2005 to 2011, Pedersen was also Chief Commercial Officer and responsible for Lundbeck’s global sales and marketing activities. The years prior to Lundbeck he worked for Ciba-Geigy (now Novartis) during a number of years in Denmark, Switzerland and South Africa. Pedersen has altogehter worked for more than 30 years in the pharmaceutical industry and also has extensive experience from listed companies as Chairman for 5 years in the Life Science company Chemometec A/S .He holds a Master’s degree in economics from the University of Aalborg.

Research Interest

pharmaceutical industry